Prevalencia y repercusión del síndrome locomotor en el perfil clínico de la enfermedad pulmonar obstructiva crónica

Background: Patients with Chronic Obstructive Pulmonary Disease (COPD) suffer a progressive deterioration of functional status and a decrease in independence in activities of daily living. Locomotor Syndrome (SL) is the involvement of the musculoskeletal system due to the deterioration caused by ag...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Romero-Fernández,Ramón, Calvache-Mateo,Andrés, Prados-Román,Esther, Granados-Santiago,María, Ortiz-Rubio,Araceli, Valenza,Marie Carmen
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2021
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000300378
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Background: Patients with Chronic Obstructive Pulmonary Disease (COPD) suffer a progressive deterioration of functional status and a decrease in independence in activities of daily living. Locomotor Syndrome (SL) is the involvement of the musculoskeletal system due to the deterioration caused by age. Aim: In patients with COPD, to evaluate the prevalence in LS and assess its impact on functional status and quality of life. Material and Methods: Cross sectional assessment of 259 patients with COPD. LS was evaluated with the Geriatric Locomotive Function Scale (GFLS-25). Those with a score < 16 were classified as having LS. Functional status was evaluated with dynamometry, Five Times Sit-to-Stand test, and the Modified Baecke Physical Activity Questionnaire. Functional impairment was measured with the London Chest Activity of Daily Living, and the quality of life was evaluated with EuroQol-5D. Results: LS was found in 139 patients (53%). Activity levels and muscle strength were lower in these patients. Also, they had a higher frequency of functional impairment and a lower quality of life perception. Conclusions: LS in patients with COPD impacts their functional status and quality of life.